Exploratory secondary analysis of a midazolam-controlled trial of IV ketamine in suicidal depression: waking saliva cortisol rose significantly 24 h after ketamine (p=0.0025). The rise had a small, non-significant correlation with reduced suicidal ideation (r=−0.25, p=0.052).
Secondary analysis
Choo et al. Increased morning cortisol after ketamine treatment for suicidal depression: Exploratory report from a randomized trial